Biohaven Ltd.
BHVN
$9.20
$0.121.32%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.28% | 23.61% | 30.70% | 30.17% | 26.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -17.87% | -0.68% | 17.07% | 31.51% | 38.78% |
| Operating Income | 17.87% | 0.68% | -17.07% | -31.51% | -38.78% |
| Income Before Tax | 27.17% | 12.81% | 3.22% | -2.10% | -71.09% |
| Income Tax Expenses | 42.58% | 96.19% | 316.95% | 122.89% | 144.21% |
| Earnings from Continuing Operations | 27.11% | 12.71% | 3.01% | -2.73% | -71.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 27.11% | 12.71% | 3.01% | -2.73% | -71.82% |
| EBIT | 17.87% | 0.68% | -17.07% | -31.51% | -38.78% |
| EBITDA | 18.26% | 0.98% | -16.88% | -31.56% | -38.91% |
| EPS Basic | 39.46% | 25.88% | 18.76% | 16.36% | -37.00% |
| Normalized Basic EPS | 28.21% | 11.49% | -1.57% | -4.86% | -7.35% |
| EPS Diluted | 39.46% | 25.88% | 18.76% | 16.36% | -37.00% |
| Normalized Diluted EPS | 28.21% | 11.49% | -1.57% | -4.86% | -7.35% |
| Average Basic Shares Outstanding | 23.59% | 17.96% | 19.65% | 25.86% | 29.20% |
| Average Diluted Shares Outstanding | 23.59% | 17.96% | 19.65% | 25.86% | 29.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |